Instructions_V5.0_p2

Home
What it is
Healthcare
Investigators
- Log In
- Contact
Contact

Share Search En/Fr

Share Share Share Share Share

Type here & click enter

31. May 2016

Written by actinsarc

Posted in:

ActIn® SARC exclusively by Nanobiotix, 2015.
NBTXR3 is currently under development in clinical studies with the purpose of obtaining a CE mark in the future.
At the moment NBTXR3 does not bear a CE mark and is not permitted to be placed on the market or put into service until NBTXR3 has obtained a CE mark.

Visit our compagnies homepage: www.nanobiotix.com | TERMS OF USE · IMPRINT